[1] WU J Q, FENG H J, OUYANG W, et al. Systematic evaluation of salivary gland damage following I-131 therapy in differentiated thyroid cancer patients by quantitative scintigraphy and clinical follow-up[J]. Nucl Med Commun, 2015, 36(8):819-826. [2] SAVAGE M W, SOBEL R K, HOFFMAN H T, et al. Salivary gland dysfunction and nasolacrimal duct obstruction:stenotic changes following I-131 therapy[J]. Ophthalmic Plast Reconstr Surg, 2015, 31(3):e50-e52. [3] ALBANO D, BERTAGNA F, PANAROTTO M B, et al. Early and late adverse effects of radioiodine for pediatric differentiated thyroid cancer[J]. Pediatr Blood Cancer, 2017, 64(11):e26595. [4] ISH-SHALOM S, DURLESHTER L, SEGAL E, et al. Sialochemical and oxidative analyses in radioactive I-131-treated patients with thyroid carcinoma[J]. Eur J Endocrinol, 2008, 158(5):677-681. [5] FALLAHI B, BEIKI D, ABEDI S M, et al. Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer?[J]. Nucl Med Commun, 2013, 34(8):777-786. [6] NAKAYAMA M, OKIZAKI A, TAKAHASHI K. A randomized controlled trial for the effectiveness of aromatherapy in decreasing salivary gland damage following radioactive iodine therapy for differentiated thyroid cancer[J]. Biomed Res Int, 2016,2016:9509810. [7] KESSLER A T, BHATT A A. Review of the major and minor salivary glands, part 1:anatomy, infectious, and inflammatory processes[J]. J Clin Imaging Sci, 2018, 8:47. [8] LI Y,TAYLOR J M,TEN HAKEN R K,et al.The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy[J].Int J Radiat Oncol Biol Phys, 2007, 67(3):660-669. [9] 文静, 高沁怡, 李亚明, 等. 分化型甲状腺癌患者131I治疗前后唾液腺功能的变化[J]. 中国医学影像技术, 2010, 26(8):1553-1556. [10] CHARALAMBOUS A. Seeking optimal management for radioactive iodine therapy-induced adverse effects[J]. Asia Pac J Oncol Nurs, 2017, 4(4):319-322. [11] MARUOKA Y, BABA S, ISODA T, et al. A functional scoring system based on salivary gland scintigraphy for evaluating salivary gland dysfunction secondary to 131I therapy in patients with differentiated thyroid carcinoma[J]. J Clin Diagn Res, 2017, 11(8):TC23-TC28. [12] 许杰华, 程木华, 苏宇雄, 等. 改良半定量唾液腺动态显像分析腮腺功能方法初探[J]. 中国医学影像学杂志, 2008, 16(5):344-347. [13] 李林. 分化型甲状腺癌131I治疗:综合评估患者获益和风险[J].中华核医学与分子影像杂志, 2016, 36(5):381-383. [14] DANIEL F I, LIMA L D, GRANDO L J, et al. Salivary evaluation in radioactive 131I treated patients with thyroid carcinoma[J]. Acta Odontol Scand, 2018, 76(2):148-152. [15] 何静,程义壮,刘学公. 131I治疗分化型甲状腺癌引起唾液腺损伤的研究进展[J]. 中华现代护理杂志, 2012, 18(25):3076-3078. [16] UPADHYAYA A, ZHOU PP, MENG ZW, et al. Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differentiated thyroid cancer:A randomized-controlled trial[J]. Nucl Med Commun, 2017, 38(11):891-903. [17] SON H, LEE S M, YOON R G, et al. Effect of selenium supplementation for protection of salivary glands from iodine-131 radiation damage in patients with differentiated thyroid cancer[J]. Hell J Nucl Med, 2017, 20(1):62-70. [18] UPADHYAYA A, MENG ZW, WANG P, et al. Effects of first radioiodine ablation on functions of salivary glands in patients with differentiated thyroid cancer[J]. Medicine (Baltimore), 2017, 96(25):e7164. [19] HAGHIGHATAFSHAR M, NOWSHAD R, ETEMADI Z, et al. The effect of chewing-gum on dose rate of salivary gland in differentiated thyroid carcinoma patients treated with radioiodine[J]. Q J Nucl Med Mol Imaging, 2018. DOI:10.23736/S1824-4785.18.03078-9. [20] 王澎, 孟召伟, 谭建, 等. 维生素E对术后首次行131I治疗的分化型甲状腺癌患者唾液腺功能的保护作用[J]. 中华核医学与分子影像杂志, 2016, 36(5):398-401. |